DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Lubiprostone
Lubiprostone
Gastrointestinal (GI) Motility, Chronic Therapeutic Class Review
Inflammatory Bowel Disease Irritable Bowel Syndrome
Therapeutic Class Overview Irritable Bowel Syndrome Agents
United States Patent (10) Patent No.: US 8,969,514 B2 Shailubhai (45) Date of Patent: Mar
Amitiza (Lubiprostone) Capsule, 24 Mcg and 8 Mcg
Identification of Pparγ Ligands with One-Dimensional Drug Profile Matching
Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-Mediated Pathway
Cytarabine Analogues by Ion-Pairing LC-MS/MS
Pharmaceuticals As Environmental Contaminants
Interactions with HBV Treatment
2015.09 IBS Drug Class Review.Pdf
OUH Formulary Approved for Use in Breast Surgery
Preferred Drug List (PDL) Lista De Medicamentos Preferidos (PDL)
Biotrial Bioanalytical Services Inc. Global List of Validated Bioanalytical Assays
Drugs of Choice 2019
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
FDA Denial of Petition on Amitiza
PDL)/Non-Preferred Drug List (NPDL
Top View
Use of Lubiprostone in Constipating Disorders and Its Potential for Opioid-Induced Bowel Dysfunction
Brand Generic Guide
Medicaid List of Covered Drugs (Formulary)
Lubiprostone
DRUG REFERENCE GUIDE Pharmacy Solutions | Durable Medical Equipment | Case Management | Utilization Services Frequently Prescribed Medications by Brand Name
Prescription Drug List Changes
CRITERIA for DRUG COVERAGE Lubiprostone (Amitiza)
NYP ACN-PAP Formulary: Fall 2009 A. 8-MOP (Methoxsalen) Amitiza
Treatment of an Acetaminophen Overdose Mate M
Amitiza and Linzess
Potentially Harmful Drugs in the Elderly: Beers List and More
NYS Medicaid Fee-For-Service Preferred Drug List PREFERRED DRUG LIST – TABLE of CONTENTS I
Management of Chronic Constipation in Adults
July 1, 2021 Premium Formulary Exclusions & Preferred Specialty Prior Authorization Requirements
Lubiprostone Prevents NSAID-Induced Small Intestinal Damage by Suppressing the Expression of Inflammatory Mediators Via EP4 Receptors
Amitiza (Lubiprostone) Capsules • Patients Taking Amitiza May Experience Dyspnea Within an Initial U.S
Study Report Number: SAG/0211PFC-1131-01 Version Number: 1.0
A Treatment Guide to Parkinson's Disease
IBS-Monograph-2018.Pdf
LUBIPROSTONE Capsules, for Oral Use Lubiprostone Lubiprostone
Lubiprostone for the Treatment of Functional Constipation in Children
Serve You Rx Select Formulary Exclusions
Factors Associated with the Use of Gastrointestinal Medicines Among Older People with Intellectual Disabilities in Ireland
Approved Formulary Drug List
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Prostaglandin E2-Induced Colonic Secretion in Patients with And
The Use of Antidepressants in the Treatment of Irritable Bowel Syndrome and Other Functional GI Disorders Christine B
FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
Paragraph IV Patent Certifications (PPIV)
Interactions with PBC Agents
Sucampo Pharmaceuticals, Inc. (Exact Name of Registrant As Specified in Charter)
Drug-Drug Interactions Leading to Adverse Drug Reactions with Rivaroxaban: a Systematic Review of the Literature and Analysis of Vigibase
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome
Definition of Pain, Allodynia, & Hyperalgesia
Amitiza® (Lubiprostone)
Lubiprostone Increases Small Intestinal Smooth Muscle Contractions Through a Prostaglandin E Receptor 1 (EP1)-Mediated Pathway
Clubbed Digits Presumably Caused by Lubiprostone
Amitiza® (Lubiprostone)